Advances in the pharmacotherapy of alcoholism: challenging misconceptions.
This article highlights the proceedings of a symposium presented at the 28th Annual Scientific Meeting of the Research Society on Alcoholism in Santa Barbara, CA, June 27, 2005. The organizer and chair was Henry R. Kranzler. The presentations included: (1) Introduction, by Henry R. Kranzler; (2) Neurobiology of Alcohol Dependence: Implications for Medical Treatment, by George Koob; (3) Advances in Alcoholism Pharmacotherapy, by Henry R. Kranzler; (4) Patient Acceptance of Alcoholism Pharmacotherapy, by David R. Gastfriend; (5) System Challenges in the Adoption of Pharmacotherapy, by Robert M. Swift; and (6) Pharmacotherapy for Alcohol Dependence: Strengths, Challenges, and Future Directions, by Mark L. Willenbring.
Kranzler
Henry R
HR
Department of Psychiatry, University of Connecticut Health Center, Farmington, Connecticut, USA. kranzler@psychiatry.uchc.edu
Koob
George
G
Gastfriend
David R
DR
Swift
Robert M
RM
Willenbring
Mark L
ML
D000427:Alcohol Deterrents / Q000009:adverse effects / Q000627:therapeutic use*; D000437:Alcoholism / Q000503:physiopathology / Q000534:rehabilitation*; D000679:Amygdala / Q000187:drug effects / Q000503:physiopathology; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D003346:Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000502:physiology; D006801:Humans; D009042:Motivation; D018377:Neurotransmitter Agents / Q000378:metabolism; D009714:Nucleus Accumbens / Q000187:drug effects / Q000503:physiopathology; D010342:Patient Acceptance of Health Care; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology / Q000534:rehabilitation; D016896:Treatment Outcome
D000427:Alcohol Deterrents; D018377:Neurotransmitter Agents; D003346:Corticotropin-Releasing Hormone